U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H24N4O
Molecular Weight 372.4629
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BZODZ-EPYR

SMILES

C(CN1C=C(C2=NC(CC3=CC=CC=C3)=NO2)C4=C1C=CC=C4)N5CCCC5

InChI

InChIKey=RUVOQWMACBDQDK-UHFFFAOYSA-N
InChI=1S/C23H24N4O/c1-2-8-18(9-3-1)16-22-24-23(28-25-22)20-17-27(15-14-26-12-6-7-13-26)21-11-5-4-10-19(20)21/h1-5,8-11,17H,6-7,12-16H2

HIDE SMILES / InChI

Molecular Formula C23H24N4O
Molecular Weight 372.4629
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:06:47 UTC 2023
Edited
by admin
on Sat Dec 16 19:06:47 UTC 2023
Record UNII
WSQ49D7D2Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BZODZ-EPYR
Common Name English
3-BENZYL-5-(1-(2-PYRROLIDIN-1-YLETHYL)-1H-INDOL-3-YL)-1,2,4-OXADIAZOLE
Systematic Name English
1H-INDOLE, 3-(3-(PHENYLMETHYL)-1,2,4-OXADIAZOL-5-YL)-1-(2-(1-PYRROLIDINYL)ETHYL)-
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-BzODZ-EPyr
Created by admin on Sat Dec 16 19:06:47 UTC 2023 , Edited by admin on Sat Dec 16 19:06:47 UTC 2023
Code System Code Type Description
WIKIPEDIA
BZODZ-EPYR
Created by admin on Sat Dec 16 19:06:47 UTC 2023 , Edited by admin on Sat Dec 16 19:06:47 UTC 2023
PRIMARY BzODZ-EPyr is an indole based synthetic cannabinoid that has been sold as a designer drug in Russia. It acts as a CB1 receptor agonist with a pKB value of 7.2 and demonstrates that replacing the ketone in 3-carbonylindoles with an oxadiazole spacer does generally not lead to activity loss.
PUBCHEM
9842447
Created by admin on Sat Dec 16 19:06:47 UTC 2023 , Edited by admin on Sat Dec 16 19:06:47 UTC 2023
PRIMARY
CAS
422564-85-0
Created by admin on Sat Dec 16 19:06:47 UTC 2023 , Edited by admin on Sat Dec 16 19:06:47 UTC 2023
PRIMARY
FDA UNII
WSQ49D7D2Q
Created by admin on Sat Dec 16 19:06:47 UTC 2023 , Edited by admin on Sat Dec 16 19:06:47 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY